SECsense Logo

PAVmed Inc. 8-K Report: Key Insights on Common Stock & Series Z Warrants

$PAVM
Form 8-K
Filed on: 2025-02-21
Source
PAVmed Inc. 8-K Report: Key Insights on Common Stock & Series Z Warrants

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Identification:
  • Entity Name: PAVmed Inc.
  • CIK Number: 0001624326.
  • Location: 360 Madison Avenue, 25th Floor, New York, NY 10017.
  • Contact Information: (917) 813-1828.
  1. Report Type:
  • Filing Type: Form 8-K.
  • Filing Date: February 18, 2025.
  1. Securities Information:
  • Common Stock:
    • Par Value: $0.001 per share.
    • Ticker Symbol: PAVM (listed on NASDAQ).
  • Series Z Warrants:
    • Ticker Symbol: PAVMZ (also listed on NASDAQ).
  1. Financial Reporting Context:
  • The report pertains to a specific date: February 18, 2025.
  • The context suggests that it includes information about common stock and warrants to purchase common stock.
  1. Units of Measurement:
  • The financial data is reported in U.S. Dollars (USD) and shares.
  1. Key Financial Elements:
  • The report indicates that the common stock has a par value of $0.001 per share, which may be relevant for understanding the company's equity structure and potential dilution from warrants or stock options.

Summary:

This filing provides a snapshot of PAVmed Inc. as of February 18, 2025, focusing on its common stock and Series Z warrants. The low par value of the common stock suggests it may be a growth-oriented company with potential equity financing strategies. The filing serves as an important regulatory update for investors and stakeholders interested in the company's equity instruments.